105 related articles for article (PubMed ID: 23752923)
1. N-Triethylene glycol (N-TEG) as a surrogate for the N-methyl group: application to Sansalvamide A peptide analogs.
Fernández-Llamazares AI; García J; Soto-Cerrato V; Pérez-Tomás R; Spengler J; Albericio F
Chem Commun (Camb); 2013 Jul; 49(57):6430-2. PubMed ID: 23752923
[TBL] [Abstract][Full Text] [Related]
2. Identification of Sansalvamide a analog potent against pancreatic cancer cell lines.
Pan PS; McGuire KL; McAlpine SR
Bioorg Med Chem Lett; 2007 Sep; 17(18):5072-7. PubMed ID: 17689077
[TBL] [Abstract][Full Text] [Related]
3. N-methylsansalvamide a peptide analogues. Potent new antitumor agents.
Liu S; Gu W; Lo D; Ding XZ; Ujiki M; Adrian TE; Soff GA; Silverman RB
J Med Chem; 2005 May; 48(10):3630-8. PubMed ID: 15887970
[TBL] [Abstract][Full Text] [Related]
4. Scaffold targeting drug-resistant colon cancers.
Otrubova K; McGuire KL; McAlpine SR
J Med Chem; 2007 May; 50(9):1999-2002. PubMed ID: 17411027
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles.
Davis MR; Styers TJ; Rodriguez RA; Pan PS; Vasko RC; McAlpine SR
Org Lett; 2008 Jan; 10(2):177-80. PubMed ID: 18095697
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity of novel sansalvamide A derivatives.
Carroll CL; Johnston JV; Kekec A; Brown JD; Parry E; Cajica J; Medina I; Cook KM; Corral R; Pan PS; McAlpine SR
Org Lett; 2005 Aug; 7(16):3481-4. PubMed ID: 16048322
[TBL] [Abstract][Full Text] [Related]
8. NW-G03, a related cyclic hexapeptide compound of NW-G01, produced by Streptomyces alboflavus 313.
Guo Z; Shen L; Zhang J; Xin H; Liu W; Ji Z; Wu W
J Antibiot (Tokyo); 2011 Dec; 64(12):789-94. PubMed ID: 22027913
[No Abstract] [Full Text] [Related]
9. In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides.
Zhang BZ; Wang KR; Yan JX; Zhang W; Song JJ; Ni JM; Wang R
Peptides; 2010 Apr; 31(4):568-73. PubMed ID: 20045716
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action.
Alexander LD; Sellers RP; Davis MR; Ardi VC; Johnson VA; Vasko RC; McAlpine SR
J Med Chem; 2009 Dec; 52(24):7927-30. PubMed ID: 20014866
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of platinum complex immobilized by branched polyethylene glycol.
Ren Y; Zhang H; Huang J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4479-83. PubMed ID: 16085413
[TBL] [Abstract][Full Text] [Related]
12. Chondramide C: synthesis, configurational assignment, and structure-activity relationship studies.
Eggert U; Diestel R; Sasse F; Jansen R; Kunze B; Kalesse M
Angew Chem Int Ed Engl; 2008; 47(34):6478-82. PubMed ID: 18624309
[No Abstract] [Full Text] [Related]
13. Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based polyelectrolyte complex.
Tseng SJ; Zeng YF; Deng YF; Yang PC; Liu JR; Kempson IM
Chem Commun (Camb); 2013 Apr; 49(26):2670-2. PubMed ID: 23435386
[TBL] [Abstract][Full Text] [Related]
14. Sansalvamide induces pancreatic cancer growth arrest through changes in the cell cycle.
Heiferman MJ; Salabat MR; Ujiki MB; Strouch MJ; Cheon EC; Silverman RB; Bentrem DJ
Anticancer Res; 2010 Jan; 30(1):73-8. PubMed ID: 20150619
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives.
Otrubova K; Styers TJ; Pan PS; Rodriguez R; McGuire KL; McAlpine SR
Chem Commun (Camb); 2006 Mar; (9):1033-4. PubMed ID: 16491200
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of c7-demethyl largazole analogues.
Chen F; Gao AH; Li J; Nan FJ
ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162
[No Abstract] [Full Text] [Related]
17. Structure-activity relationship of kahalalide F synthetic analogues.
Jiménez JC; López-Macià A; Gracia C; Varón S; Carrascal M; Caba JM; Royo M; Francesch AM; Cuevas C; Giralt E; Albericio F
J Med Chem; 2008 Aug; 51(16):4920-31. PubMed ID: 18672864
[TBL] [Abstract][Full Text] [Related]
18. Total syntheses and biological evaluation of miuraenamides.
Karmann L; Schultz K; Herrmann J; Müller R; Kazmaier U
Angew Chem Int Ed Engl; 2015 Apr; 54(15):4502-7. PubMed ID: 25688545
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29.
Styers TJ; Kekec A; Rodriguez R; Brown JD; Cajica J; Pan PS; Parry E; Carroll CL; Medina I; Corral R; Lapera S; Otrubova K; Pan CM; McGuire KL; McAlpine SR
Bioorg Med Chem; 2006 Aug; 14(16):5625-31. PubMed ID: 16697205
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of IB-01212 by multiple N-methylations of peptide bonds.
Nabika R; Oishi S; Misu R; Ohno H; Fujii N
Bioorg Med Chem; 2014 Nov; 22(21):6156-62. PubMed ID: 25261926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
